G.B. Frisoni

Discipline

Psychologie (9) Sociologie (1)

Type de document

Articles (15) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Alzheimer's disease (10) Human beings (9) Dementia (9) Biochemical markers (8) biomarqueur (7) Amyloid (7) Brain (7) Mild cognitive impairment (7) plasma (7) cerveau (7) pathologie (6) information (6) âge (6) Performance (6) Patients (6) Pathology (6) Memory (6) Cognition (6) Age (6) Age (6) Patients (6) Performance (6) protéine (5) maladie (5) Apolipoprotein E (5) Weights and measures (5) Proteins (5) Persons (5) Evidence (5) Blood (5)

Documents écrit par G.B. Frisoni (15) | parle de G.B. Frisoni (0)

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
L. Shi et al.
The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19.
G. Bommarito et al.
Dementia prevention in memory clinics: recommendations from the European task force for brain health services.
G.B. Frisoni et al.
Musical and psychomotor interventions for cognitive, sensorimotor, and cerebral decline in patients with Mild Cognitive Impairment (COPE): a study protocol for a multicentric randomized controlled study.
C.E. James et al. (6 févr. 2023)
Le Registre suisse pour la santé du cerveau - Une infrastructure nationale pour la recherche sur la maladie d’Alzheimer [The Swiss Brain Health Registry : a national infrastructure for Alzheimer's research]
M. Boillat et al. (15 déc. 2021)
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.
A. Brioschi Guevara et al. (11 oct. 2021)
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
L. Shi et al. (2021)
Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts.
A. Redolfi et al. (2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
Diagnostic et prise en charge des démences: des concepts en pleine evolution.
C. Büla et al. (2016)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
W.J. Jansen et al. (2015)